13F Pro quality score
Rank #184 of 2,925TOP 10%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
AI-extracted from the 10-Q filed 2026-08-27 — Q2 FY2027 (quarter ended July 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Total revenue rose 8% to $350.7M as custodial revenue climbed 10% to $175.9M on a 3.83% HSA cash yield, lifting net income 10% to $65.6M.
Average annualized yield on HSA cash rose from 3.51% to 3.83% plus a $0.4B increase in average daily HSA cash
Increases in marketplace revenue, Total Accounts, and HSA investments, partially offset by lower average service fees per account
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Reported revenue, net income and operating margin by fiscal year, from HEALTHEQUITY, INC.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2026 | 10-K | $1.3B | $215.2M | 24.6% |
| FY 2025 | 10-K | $1.2B | $96.7M | 13.5% |
| FY 2024 | 10-K | $999.6M | $55.7M | 11.8% |
| FY 2023 | 10-K | $861.7M | $-26.1M | 1.1% |
| FY 2022 | 10-K | $756.6M | $-44.3M | -3.2% |
| FY 2021 | 10-K | $733.6M | $8.8M | 4.6% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
12 transactions in HQY reported by 6 members of Congress under the STOCK Act, most recent trade Jul 10, 2026. Reported transactions, not recommendations.
HEALTHEQUITY, INC. (HQY) stock profile, AI quality score, and SEC EDGAR financial data, a Industrials sector company. 13F Pro's AI-powered ranking engine scores HQY at 71.3/100 on a composite quality score built from its SEC filings, placing it at rank #184 of 2,925 stocks — the top 10% of the AI-ranked universe. HQY scores in the top quartile across free cash flow (89.2), profitability (81.7), institutional flow (81.0). Shareholder dilution risk is elevated at 22.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2027), HEALTHEQUITY, INC. reports quarterly revenue of $350.7M, net income of $65.6M, an operating margin of 28.1%. Top institutional holders of HQY by reported 13-F value include BlackRock, WASATCH ADVISORS, MORGAN STANLEY, based on the most recent SEC filings. HQY trades on the Nasdaq exchange and files with the SEC under CIK 1428336. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HQY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HEALTHEQUITY, INC. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1428336 →